Global Natural Killer Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 120423
  • calendar_today Published On: Oct, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Natural Killer Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Natural Killer Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 23.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 399.9 million by 2025, from USD 173.8 million in 2019.

Market segmentation

Natural Killer Cell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Natural Killer Cell Therapy market has been segmented into:

NK Cell Therapies

NK Cell Directed Antibodies

By Application, Natural Killer Cell Therapy has been segmented into:

Cancer

Gastrointestinal Diseases

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Natural Killer Cell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Natural Killer Cell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Natural Killer Cell Therapy market.

The report offers in-depth assessment of the growth and other aspects of the Natural Killer Cell Therapy market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Natural Killer Cell Therapy Market Share Analysis

Natural Killer Cell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Natural Killer Cell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Natural Killer Cell Therapy sales, revenue and market share for each player covered in this report.

The major players covered in Natural Killer Cell Therapy are:

Nektar Therapeutics

Kiadis Pharma

Chipscreen Biosciences

Innate Pharma SA

Dragonfly Therapeutics

Affimed

NantKwest

Fate Therapeutics

Glycostem Therapeutics

Nkarta Therapeutics

Among other players domestic and global, Natural Killer Cell Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Natural Killer Cell Therapy Market Overview

1.1 Product Overview and Scope of Natural Killer Cell Therapy

1.2 Classification of Natural Killer Cell Therapy by Type

1.2.1 Global Natural Killer Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Natural Killer Cell Therapy Revenue Market Share by Type in 2019

1.2.3 NK Cell Therapies

1.2.4 NK Cell Directed Antibodies

1.3 Global Natural Killer Cell Therapy Market by Application

1.3.1 Overview: Global Natural Killer Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Cancer

1.3.3 Gastrointestinal Diseases

1.3.4 Others

1.4 Global Natural Killer Cell Therapy Market by Regions

1.4.1 Global Natural Killer Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Natural Killer Cell Therapy (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Natural Killer Cell Therapy Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Natural Killer Cell Therapy Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Natural Killer Cell Therapy Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Natural Killer Cell Therapy Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Natural Killer Cell Therapy Status and Prospect (2015-2025)

2 Company Profiles

2.1 Nektar Therapeutics

2.1.1 Nektar Therapeutics Details

2.1.2 Nektar Therapeutics Major Business

2.1.3 Nektar Therapeutics SWOT Analysis

2.1.4 Nektar Therapeutics Product and Services

2.1.5 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.2 Kiadis Pharma

2.2.1 Kiadis Pharma Details

2.2.2 Kiadis Pharma Major Business

2.2.3 Kiadis Pharma SWOT Analysis

2.2.4 Kiadis Pharma Product and Services

2.2.5 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.3 Chipscreen Biosciences

2.3.1 Chipscreen Biosciences Details

2.3.2 Chipscreen Biosciences Major Business

2.3.3 Chipscreen Biosciences SWOT Analysis

2.3.4 Chipscreen Biosciences Product and Services

2.3.5 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.4 Innate Pharma SA

2.4.1 Innate Pharma SA Details

2.4.2 Innate Pharma SA Major Business

2.4.3 Innate Pharma SA SWOT Analysis

2.4.4 Innate Pharma SA Product and Services

2.4.5 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.5 Dragonfly Therapeutics

2.5.1 Dragonfly Therapeutics Details

2.5.2 Dragonfly Therapeutics Major Business

2.5.3 Dragonfly Therapeutics SWOT Analysis

2.5.4 Dragonfly Therapeutics Product and Services

2.5.5 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.6 Affimed

2.6.1 Affimed Details

2.6.2 Affimed Major Business

2.6.3 Affimed Product and Services

2.6.4 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.7 NantKwest

2.7.1 NantKwest Details

2.7.2 NantKwest Major Business

2.7.3 NantKwest Product and Services

2.7.4 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.8 Fate Therapeutics

2.8.1 Fate Therapeutics Details

2.8.2 Fate Therapeutics Major Business

2.8.3 Fate Therapeutics Product and Services

2.8.4 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.9 Glycostem Therapeutics

2.9.1 Glycostem Therapeutics Details

2.9.2 Glycostem Therapeutics Major Business

2.9.3 Glycostem Therapeutics Product and Services

2.9.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.10 Nkarta Therapeutics

2.10.1 Nkarta Therapeutics Details

2.10.2 Nkarta Therapeutics Major Business

2.10.3 Nkarta Therapeutics Product and Services

2.10.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Natural Killer Cell Therapy Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Natural Killer Cell Therapy Players Market Share

3.2.2 Top 10 Natural Killer Cell Therapy Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Natural Killer Cell Therapy Revenue and Market Share by Regions

4.2 North America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

4.3 Europe Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

4.5 South America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

5 North America Natural Killer Cell Therapy Revenue by Countries

5.1 North America Natural Killer Cell Therapy Revenue by Countries (2015-2020)

5.2 USA Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

5.3 Canada Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

5.4 Mexico Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

6 Europe Natural Killer Cell Therapy Revenue by Countries

6.1 Europe Natural Killer Cell Therapy Revenue by Countries (2015-2020)

6.2 Germany Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

6.3 UK Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

6.4 France Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

6.5 Russia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

6.6 Italy Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Natural Killer Cell Therapy Revenue by Countries

7.1 Asia-Pacific Natural Killer Cell Therapy Revenue by Countries (2015-2020)

7.2 China Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

7.3 Japan Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

7.4 Korea Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

7.5 India Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

8 South America Natural Killer Cell Therapy Revenue by Countries

8.1 South America Natural Killer Cell Therapy Revenue by Countries (2015-2020)

8.2 Brazil Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

8.3 Argentina Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Natural Killer Cell Therapy by Countries

9.1 Middle East & Africa Natural Killer Cell Therapy Revenue by Countries (2015-2020)

9.2 Saudi Arabia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

9.3 UAE Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

9.4 Egypt Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

9.5 South Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Natural Killer Cell Therapy Revenue and Market Share by Type (2015-2020)

10.2 Global Natural Killer Cell Therapy Market Forecast by Type (2019-2024)

10.3 NK Cell Therapies Revenue Growth Rate (2015-2025)

10.4 NK Cell Directed Antibodies Revenue Growth Rate (2015-2025)

11 Global Natural Killer Cell Therapy Market Segment by Application

11.1 Global Natural Killer Cell Therapy Revenue Market Share by Application (2015-2020)

11.2 Natural Killer Cell Therapy Market Forecast by Application (2019-2024)

11.3 Cancer Revenue Growth (2015-2020)

11.4 Gastrointestinal Diseases Revenue Growth (2015-2020)

11.5 Others Revenue Growth (2015-2020)

12 Global Natural Killer Cell Therapy Market Size Forecast (2021-2025)

12.1 Global Natural Killer Cell Therapy Market Size Forecast (2021-2025)

12.2 Global Natural Killer Cell Therapy Market Forecast by Regions (2021-2025)

12.3 North America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

12.4 Europe Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

12.6 South America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Natural Killer Cell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Natural Killer Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Natural Killer Cell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Natural Killer Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global Natural Killer Cell Therapy Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Nektar Therapeutics Corporate Information, Location and Competitors

Table 7. Nektar Therapeutics Natural Killer Cell Therapy Major Business

Table 8. Nektar Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 9. Nektar Therapeutics SWOT Analysis

Table 10. Nektar Therapeutics Natural Killer Cell Therapy Product and Solutions

Table 11. Nektar Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. Kiadis Pharma Corporate Information, Location and Competitors

Table 13. Kiadis Pharma Natural Killer Cell Therapy Major Business

Table 14. Kiadis Pharma Natural Killer Cell Therapy Total Revenue (USD Million) (2018-2019)

Table 15. Kiadis Pharma SWOT Analysis

Table 16. Kiadis Pharma Natural Killer Cell Therapy Product and Solutions

Table 17. Kiadis Pharma Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. Chipscreen Biosciences Corporate Information, Location and Competitors

Table 19. Chipscreen Biosciences Natural Killer Cell Therapy Major Business

Table 20. Chipscreen Biosciences Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 21. Chipscreen Biosciences SWOT Analysis

Table 22. Chipscreen Biosciences Natural Killer Cell Therapy Product and Solutions

Table 23. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. Innate Pharma SA Corporate Information, Location and Competitors

Table 25. Innate Pharma SA Natural Killer Cell Therapy Major Business

Table 26. Innate Pharma SA Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 27. Innate Pharma SA SWOT Analysis

Table 28. Innate Pharma SA Natural Killer Cell Therapy Product and Solutions

Table 29. Innate Pharma SA Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. Dragonfly Therapeutics Corporate Information, Location and Competitors

Table 31. Dragonfly Therapeutics Natural Killer Cell Therapy Major Business

Table 32. Dragonfly Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 33. Dragonfly Therapeutics SWOT Analysis

Table 34. Dragonfly Therapeutics Natural Killer Cell Therapy Product and Solutions

Table 35. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Affimed Corporate Information, Location and Competitors

Table 37. Affimed Natural Killer Cell Therapy Major Business

Table 38. Affimed Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 39. Affimed SWOT Analysis

Table 40. Affimed Natural Killer Cell Therapy Product and Solutions

Table 41. Affimed Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. NantKwest Corporate Information, Location and Competitors

Table 43. NantKwest Natural Killer Cell Therapy Major Business

Table 44. NantKwest Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 45. NantKwest SWOT Analysis

Table 46. NantKwest Natural Killer Cell Therapy Product and Solutions

Table 47. NantKwest Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. Fate Therapeutics Corporate Information, Location and Competitors

Table 49. Fate Therapeutics Natural Killer Cell Therapy Major Business

Table 50. Fate Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 51. Fate Therapeutics SWOT Analysis

Table 52. Fate Therapeutics Natural Killer Cell Therapy Product and Solutions

Table 53. Fate Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. Glycostem Therapeutics Corporate Information, Location and Competitors

Table 55. Glycostem Therapeutics Natural Killer Cell Therapy Major Business

Table 56. Glycostem Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 57. Glycostem Therapeutics SWOT Analysis

Table 58. Glycostem Therapeutics Natural Killer Cell Therapy Product and Solutions

Table 59. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 60. Nkarta Therapeutics Corporate Information, Location and Competitors

Table 61. Nkarta Therapeutics Natural Killer Cell Therapy Major Business

Table 62. Nkarta Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)

Table 63. Nkarta Therapeutics SWOT Analysis

Table 64. Nkarta Therapeutics Natural Killer Cell Therapy Product and Solutions

Table 65. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 66. Global Natural Killer Cell Therapy Revenue (Million USD) by Players (2015-2020)

Table 67. Global Natural Killer Cell Therapy Revenue Share by Players (2015-2020)

Table 68. Global Natural Killer Cell Therapy Revenue (Million USD) by Regions (2015-2020)

Table 69. Global Natural Killer Cell Therapy Revenue Market Share by Regions (2015-2020)

Table 70. North America Natural Killer Cell Therapy Revenue by Countries (2015-2020)

Table 71. North America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Table 72. Europe Natural Killer Cell Therapy Revenue (Million USD) by Countries (2015-2020)

Table 73. Asia-Pacific Natural Killer Cell Therapy Revenue (Million USD) by Countries (2015-2020)

Table 74. South America Natural Killer Cell Therapy Revenue by Countries (2015-2020)

Table 75. South America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Table 76. Middle East and Africa Natural Killer Cell Therapy Revenue (Million USD) by Countries (2015-2020)

Table 77. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Table 78. Global Natural Killer Cell Therapy Revenue (Million USD) by Type (2015-2020)

Table 79. Global Natural Killer Cell Therapy Revenue Share by Type (2015-2020)

Table 80. Global Natural Killer Cell Therapy Revenue Forecast by Type (2021-2025)

Table 81. Global Natural Killer Cell Therapy Revenue by Application (2015-2020)

Table 82. Global Natural Killer Cell Therapy Revenue Share by Application (2015-2020)

Table 83. Global Natural Killer Cell Therapy Revenue Forecast by Application (2021-2025)

Table 84. Global Natural Killer Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Natural Killer Cell Therapy Picture

Figure 2. Global Natural Killer Cell Therapy Revenue Market Share by Type in 2019

Figure 3. NK Cell Therapies Picture

Figure 4. NK Cell Directed Antibodies Picture

Figure 5. Natural Killer Cell Therapy Revenue Market Share by Application in 2019

Figure 6. Cancer Picture

Figure 7. Gastrointestinal Diseases Picture

Figure 8. Others Picture

Figure 9. Global Natural Killer Cell Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 10. North America Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 11. Europe Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 12. Asia-Pacific Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 13. South America Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Middle East and Africa Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Global Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Global Natural Killer Cell Therapy Revenue Share by Players in 2019

Figure 17. Global Top 5 Players Natural Killer Cell Therapy Revenue Market Share in 2019

Figure 18. Global Top 10 Players Natural Killer Cell Therapy Revenue Market Share in 2019

Figure 19. Key Players Market Share Trend

Figure 20. Global Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 21. Global Natural Killer Cell Therapy Revenue Market Share by Regions (2015-2020)

Figure 22. Global Natural Killer Cell Therapy Revenue Market Share by Regions in 2018

Figure 23. North America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 24. Europe Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 25. Asia-Pacific Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 26. South America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 27. Middle East and Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 28. North America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure 29. North America Natural Killer Cell Therapy Revenue Market Share by Countries in 2019

Figure 30. USA Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 31. Canada Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 32. Mexico Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 33. Europe Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure 34. Europe Natural Killer Cell Therapy Revenue Market Share by Countries in 2019

Figure 35. Germany Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 36. UK Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 37. France Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 38. Russia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 39. Italy Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 40. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure 41. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Countries in 2019

Figure 42. China Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 43. Japan Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 44. Korea Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 45. India Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 46. Southeast Asia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 47. South America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure 48. South America Natural Killer Cell Therapy Revenue Market Share by Countries in 2019

Figure 49. Brazil Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 50. Argentina Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 51. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure 52. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Countries in 2019

Figure 53. Saudi Arabia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 54. UAE Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 55. Egypt Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 56. South Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)

Figure 57. Global Natural Killer Cell Therapy Revenue Share by Type (2015-2020)

Figure 58. Global Natural Killer Cell Therapy Revenue Share by Type in 2019

Figure 59. Global Natural Killer Cell Therapy Market Share Forecast by Type (2021-2025)

Figure 60. Global NK Cell Therapies Revenue Growth Rate (2015-2020)

Figure 61. Global NK Cell Directed Antibodies Revenue Growth Rate (2015-2020)

Figure 62. Global Natural Killer Cell Therapy Revenue Share by Application (2015-2020)

Figure 63. Global Natural Killer Cell Therapy Revenue Share by Application in 2019

Figure 64. Global Natural Killer Cell Therapy Market Share Forecast by Application (2021-2025)

Figure 65. Global Cancer Revenue Growth Rate (2015-2020)

Figure 66. Global Gastrointestinal Diseases Revenue Growth Rate (2015-2020)

Figure 67. Global Others Revenue Growth Rate (2015-2020)

Figure 68. Global Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 69. Global Natural Killer Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 70. Global Natural Killer Cell Therapy Revenue Market Share Forecast by Regions (2021-2025)

Figure 71. North America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

Figure 72. Europe Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

Figure 73. Asia-Pacific Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

Figure 74. South America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

Figure 75. Middle East and Africa Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz